Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$27,000.00

Developmental origins of multiple sclerosis

FY 2024-25

Summary
Canada has among the highest rates of multiple sclerosis (MS) in the world. MS is characterized by neurodegeneration as a result of loss of myelin, the protective coating around nerve axons, and oligodendrocytes, myelin producing cells in the central nervous system (CNS). In the last few years, over 200 gene mutations have been discovered in MS patients which has highlighted the role of genetics in MS predisposition, onset, and development. Remarkably, people with severe MS also experience functional deficits during brain development. We do not yet understand if and how severity risk gene variants associated with MS impact brain development, and if these developmental complications lead to impaired recovery after a demyelinating injury later in life. I will study the effect of the human CX3CR1I249/M280 variant detected in patients with severe MS, on developmental myelination, and determine functional consequences of perturbed developmental processes on a response to demyelinating injury later in life. To do this, I will use mouse models that express the pathogenic CX3CR1I249/M280 gene variant detected in people with MS (herein referred to as hM280). I will identify the effect of hM280 variant on brain development and myelin integrity. I will also test whether rescuing the process of developmental myelination in hM280 mice will protect them from severe neurodegeneration in adulthood. The results of my project may uncover a link between early brain development, genetics, and MS, and may open a new window for therapeutic interventions.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530105
Name
Low Lillian
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Developmental origins of multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Differentiation; Demyelination; Development; Fractalkine; Genetics; Mixed Analysis; Multiple Sclerosis; Myelin; Neurodegeneration; Oligodendrocyte
Abstract
Canada has among the highest rates of multiple sclerosis (MS) in the world. MS is characterized by neurodegeneration as a result of loss of myelin, the protective coating around nerve axons, and oligodendrocytes, myelin producing cells in the central nervous system (CNS). In the last few years, over 200 gene mutations have been discovered in MS patients which has highlighted the role of genetics in MS predisposition, onset, and development. Remarkably, people with severe MS also experience functional deficits during brain development. We do not yet understand if and how severity risk gene variants associated with MS impact brain development, and if these developmental complications lead to impaired recovery after a demyelinating injury later in life. I will study the effect of the human CX3CR1I249/M280 variant detected in patients with severe MS, on developmental myelination, and determine functional consequences of perturbed developmental processes on a response to demyelinating injury later in life. To do this, I will use mouse models that express the pathogenic CX3CR1I249/M280 gene variant detected in people with MS (herein referred to as hM280). I will identify the effect of hM280 variant on brain development and myelin integrity. I will also test whether rescuing the process of developmental myelination in hM280 mice will protect them from severe neurodegeneration in adulthood. The results of my project may uncover a link between early brain development, genetics, and MS, and may open a new window for therapeutic interventions.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Low, Lillian
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~